Clinical Trial Management System Market Worth $3.59 Billion by 2030
o
Meticulous Research®– a leading global
market research company, published a research report titled “Clinical Trial Management
System (CTMS) Market by Component (Software, Service), Type
(Enterprise, Site), Mode of Delivery (Web, Cloud, On-premise), End User (CRO,
Pharmaceutical & Biotech, Medical Device Companies) - Global Forecast to
2030.”
Download Free Sample Report Here: https://www.meticulousresearch.com/download-sample-report/cp_id=5456
According to this latest publication from Meticulous Research,
the global clinical trial management system (CTMS) market is expected to grow
at a CAGR of 13.5% to reach $3.59 billion by 2030. A surge in the number of
clinical trials, increasing adoption of healthcare IT, and rising government
support are the factors driving the market growth. Furthermore, increasing the
adoption of AI-based CTMS will likely offer better growth opportunities for
market expansion. Moreover, the growing trend of integrated CTMS solutions is
expected to support market growth. However, the lack of skilled healthcare
professionals to handle advanced digital solutions poses a major challenge to
the growth of the CTMS market.
Clinical Trial Management
System Market: Future Outlook
The global clinical trial management system
market study presents historical market data in terms of values (2021 and
2022), estimated current data (2023), and forecasts it for 2030 – by Component
(Software and Service), Type (Enterprise-based and Site-based), Mode of
Delivery (Web-based, Cloud-based, and On-premise), End User (Contract Research
Organizations, Pharmaceutical & Biotechnology Companies, Medical Device
Companies, and Other End Users), and Geography. The study also evaluates
industry competitors and analyzes their market share at global and regional
levels.
Based on component, the market is
segmented into software and service. The software segment is expected to
account for the largest market share in 2023, owing to the increase in
research & development expenditure, rise in the number of clinical trials,
and surge in the adoption of clinical trial management system software.
Based on type, the
enterprise-based CTMS is expected to account for the largest share of the
market in 2023. Control and connection within the organization, streamlining
and simplifying processes, and cost reduction contribute to the largest market
share.
Speak to analyst: https://www.meticulousresearch.com/speak-to-analyst/cp_id=5456
Based on end user, the contract
research organizations (CROs) segment is expected to account for the largest
share of the market in 2023. The large share can be attributed to the
increased outsourcing of clinical trials by various healthcare stakeholders,
including pharmaceutical & biotechnology companies, medical device
manufacturers, animal health companies, and a few academic institutes.
Geographic Review
This research report analyzes major
geographies and provides a comprehensive analysis of North America (U.S. and
Canada), Europe (Germany, France, U.K., Italy, Spain, and the Rest of Europe),
Asia-Pacific (China, Japan, India, and the Rest of Asia-Pacific), Latin
America (Brazil, Mexico, and Rest of Latin America), and Middle East &
Africa. Asia-Pacific is estimated to grow at the highest CAGR during the
forecast period. Increasing outsourcing of clinical trials by major and minor
stakeholders, the rising number of clinical trials in the region, and the
availability of a large patient pool drive the demand for clinical trial
management systems (CTMS).
Quick Buy: https://www.meticulousresearch.com/Checkout/50827972
Key Players
The key players operating in the global
clinical trial management system (CTMS) market are Oracle Corporation (U.S.),
SimpleTrials (U.S.), LABORATORY CORPORATION OF AMERICA HOLDINGS (U.S.), Wipro
Limited (India), Advarra, Inc. (U.S.), RealTime Software Solutions, LLC
(U.S.), Datatrak International, Inc. (U.S.), Clario (U.S.), Dassault Systèmes
(France), Veeva Systems Inc. (U.S.), PHARMASEAL (U.K.), MasterControl Inc.
(U.S.), Calyx (U.S.), IQVIA HOLDINGS INC. (U.S.), and DSG, Inc. (U.S.) among
others.
Key questions answered in
the report-
· Which are
the high-growth market segments in terms of component, type, mode of delivery,
end user, and regions/countries?
· What was
the historical market for clinical trial management systems across the globe?
· What are
the market forecasts and estimates for the period 2023–2030?
· What are
the major drivers, restraints, challenges, opportunities, and trends in the
clinical trial management system market?
· Who are
the major players in the global clinical trial management system market?
· What is
the competitive landscape, and who are the market leaders in the global
clinical trial management system market?
· What are
the recent developments in the clinical trial management system market?
· What are
the different strategies adopted by the major players in the clinical trial
management system market?
· What are
the geographical trends and high-growth regions/countries?
Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous- research
Comments
Post a Comment